Literature DB >> 9930356

The role of FDG PET in the clinical management of head and neck cancer.

M P Stokkel1, F W ten Broek, P P van Rijk.   

Abstract

Positron emission tomography (PET) with fluorodeoxyglucose (FDG) allows the visualization of metabolic tissue activity. Use of FDG in in-vivo cancer imaging is based on enhanced glycolysis in tumor cells. In vivo experiments have demonstrated the potential use of FDG PET in squamous-cell head and neck tumors and the detection of tumor involvement in lymph nodes. Since its introduction in this area, several papers have appeared on the use of this imaging modality. Indications for the use of FDG PET in patients with head and neck cancer are discussed.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9930356     DOI： 10.1016/s1368-8375(98)00050-5

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


  11 in total

Review 1.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

2.  The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.

Authors:  Sung Gwe Ahn; Sung Hoon Kim; Tae Joo Jeon; Ho Jin Cho; Sae Byeol Choi; Mi Jin Yun; Jong Doo Lee; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2011-09-09       Impact factor: 3.452

3.  Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.

Authors:  Vlad C Sandulache; Thomas J Ow; Curtis R Pickering; Mitchell J Frederick; Ge Zhou; Izabela Fokt; Melinda Davis-Malesevich; Waldemar Priebe; Jeffrey N Myers
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

Review 4.  Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.

Authors:  Vlad C Sandulache; Jeffrey N Myers
Journal:  Head Neck       Date:  2011-02-14       Impact factor: 3.147

5.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Authors:  Nitin Nitin; Alicia L Carlson; Tim Muldoon; Adel K El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

Review 6.  Glucose deprivation-induced metabolic oxidative stress and cancer therapy.

Authors:  Andrean L Simons; David M Mattson; Ken Dornfeld; Douglas R Spitz
Journal:  J Cancer Res Ther       Date:  2009-09       Impact factor: 1.805

Review 7.  Parotid metastasis from renal cell carcinoma: a case report and review of the literature.

Authors:  R Spreafico; G Nicoletti; F Ferrario; R Scanziani; M Grasso
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-10       Impact factor: 2.124

8.  New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.

Authors:  Devkumar Mustafi; Bo Peng; Sean Foxley; Marvin W Makinen; Gregory S Karczmar; Marta Zamora; John Ejnik; Heather Martin
Journal:  J Biol Inorg Chem       Date:  2009-07-02       Impact factor: 3.358

9.  Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-D-glucose correlates with increased 18F-FDG uptake as determined by PET imaging.

Authors:  Andrean L Simons; Melissa A Fath; David M Mattson; Brian J Smith; Susan A Walsh; Michael M Graham; Richard D Hichwa; John M Buatti; Ken Dornfeld; Douglas R Spitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

10.  Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Authors:  Nitin Nitin; Kelsey J Rosbach; Adel El-Naggar; Michelle Williams; Ann Gillenwater; Rebecca R Richards-Kortum
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.